Literature DB >> 2808672

Investigation by improved syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus.

A C Wong1, S A Downs.   

Abstract

Twenty-seven types of commercial tampons from five manufacturers were tested in a sealed-syringe method to determine their effect on the growth of Staphylococcus aureus and the production of toxic shock syndrome toxin 1. In this improvement of the syringe method, the available air is limited to that which is contained within the sealed syringe containing the tampon. The culture medium was buffered, and blood and CO2 were included in the incubation to better simulate the vaginal environment during menstruation. Variables of tampon weight, composition, air volume, and absorbency were examined for their effect on the production of toxic shock syndrome toxin 1. Generally, with the exception of brand E, toxin production in the presence of tampons was equal to or lower than that in a sealed control syringe containing air but no tampon.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2808672      PMCID: PMC267062          DOI: 10.1128/jcm.27.11.2482-2487.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Vaginal physiology during menstruation.

Authors:  G Wagner; B Ottesen
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

2.  Tri-state toxic-state syndrome study. I. Epidemiologic findings.

Authors:  M T Osterholm; J P Davis; R W Gibson; J S Mandel; L A Wintermeyer; C M Helms; J C Forfang; J Rondeau; J M Vergeront
Journal:  J Infect Dis       Date:  1982-04       Impact factor: 5.226

3.  Enzyme-linked immunosorbent assay for detection of staphylococcal enterotoxins in foods.

Authors:  R C Freed; M L Evenson; R F Reiser; M S Bergdoll
Journal:  Appl Environ Microbiol       Date:  1982-12       Impact factor: 4.792

4.  A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates.

Authors:  M S Bergdoll; B A Crass; R F Reiser; R N Robbins; J P Davis
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

5.  Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.

Authors:  P M Schlievert; K N Shands; B B Dan; G P Schmid; R D Nishimura
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

6.  Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors.

Authors:  P M Schlievert; D A Blomster
Journal:  J Infect Dis       Date:  1983-02       Impact factor: 5.226

7.  Tampon-induced changes in vaginal oxygen and carbon dioxide tensions.

Authors:  G Wagner; L Bohr; P Wagner; L N Petersen
Journal:  Am J Obstet Gynecol       Date:  1984-01-15       Impact factor: 8.661

8.  Risk factors for development of toxic shock syndrome. Association with a tampon brand.

Authors:  W F Schlech; K N Shands; A L Reingold; B B Dan; G P Schmid; N T Hargrett; A Hightower; L A Herwaldt; M A Neill; J D Band; J V Bennett
Journal:  JAMA       Date:  1982-08-20       Impact factor: 56.272

9.  Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases.

Authors:  K N Shands; G P Schmid; B B Dan; D Blum; R J Guidotti; N T Hargrett; R L Anderson; D L Hill; C V Broome; J D Band; D W Fraser
Journal:  N Engl J Med       Date:  1980-12-18       Impact factor: 91.245

10.  Toxic-shock syndrome associated with phage-group-I Staphylococci.

Authors:  J Todd; M Fishaut; F Kapral; T Welch
Journal:  Lancet       Date:  1978-11-25       Impact factor: 79.321

View more
  1 in total

1.  Impact of Currently Marketed Tampons and Menstrual Cups on Staphylococcus aureus Growth and Toxic Shock Syndrome Toxin 1 Production In Vitro.

Authors:  Louis Nonfoux; Myriam Chiaruzzi; Cédric Badiou; Jessica Baude; Anne Tristan; Jean Thioulouse; Daniel Muller; Claire Prigent-Combaret; Gérard Lina
Journal:  Appl Environ Microbiol       Date:  2018-05-31       Impact factor: 4.792

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.